Literature DB >> 27782697

Automatic airway-artery analysis on lung CT to quantify airway wall thickening and bronchiectasis.

Adria Perez-Rovira1, Wieying Kuo2, Jens Petersen3, Harm A W M Tiddens2, Marleen de Bruijne4.   

Abstract

PURPOSE: Bronchiectasis and airway wall thickening are commonly assessed in computed tomography (CT) by comparing the airway size with the size of the accompanying artery. Thus, in order to automate the quantification of bronchiectasis and wall thickening following a similar principle, there is a need for methods that automatically segment the airway and vascular trees, measure their size, and pair each airway branch with its accompanying artery.
METHODS: This paper combines and extends existing techniques to present a fully automated pipeline that, given a thoracic chest CT, segments, measures, and pairs airway branches with the accompanying artery, then quantifies airway wall thickening and bronchiectasis by measuring the wall-artery ratio (WAR) and lumen and outer wall airway-artery ratio (AAR). Measurements that do not use the artery size for normalization are also extracted, including wall area percentage (WAP), wall thickness ratio (WTR), and airway diameters.
RESULTS: The method was thoroughly evaluated using 8000 manual annotations of airway-artery pairs from 24 full-inspiration pediatric CT scans (12 diseased and 12 controls). Limits of agreement between the automatically and manually measured diameters were comparable to interobserver limits of agreement. Differences in automatically obtained WAR, AAR, WAP, and WTR between bronchiectatic subjects and controls were similar as when manual annotations were used: WAR and outer AAR were significantly higher in the bronchiectatic subjects (p < 0.05), but lumen AAR, WAP, and WTR were not. Only measurements that use artery size for normalization led to significant differences between groups, highlighting the importance of airway-artery pairing.
CONCLUSIONS: The fully automatic method presented in this paper could replace time-consuming manual annotations and visual scoring methods to quantify abnormal widening and thickening of airways.

Mesh:

Year:  2016        PMID: 27782697     DOI: 10.1118/1.4963214

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  7 in total

Review 1.  Semi-automatic Methods for Airway and Adjacent Vessel Measurement in Bronchiectasis Patterns in Lung HRCT Images of Cystic Fibrosis Patients.

Authors:  Zeinab Naseri; Soghra Sherafat; Hamid Abrishami Moghaddam; Mohammadreza Modaresi; Neda Pak; Fatemeh Zamani
Journal:  J Digit Imaging       Date:  2018-10       Impact factor: 4.056

Review 2.  Current state of the art MRI for the longitudinal assessment of cystic fibrosis.

Authors:  Jason C Woods; Jim M Wild; Mark O Wielpütz; John P Clancy; Hiroto Hatabu; Hans-Ulrich Kauczor; Edwin J R van Beek; Talissa A Altes
Journal:  J Magn Reson Imaging       Date:  2019-12-17       Impact factor: 4.813

3.  An unsupervised semi-automated pulmonary nodule segmentation method based on enhanced region growing.

Authors:  He Ren; Lingxiao Zhou; Gang Liu; Xueqing Peng; Weiya Shi; Huilin Xu; Fei Shan; Lei Liu
Journal:  Quant Imaging Med Surg       Date:  2020-01

4.  Diagnosis of bronchiectasis and airway wall thickening in children with cystic fibrosis: Objective airway-artery quantification.

Authors:  Wieying Kuo; Marleen de Bruijne; Jens Petersen; Kazem Nasserinejad; Hadiye Ozturk; Yong Chen; Adria Perez-Rovira; Harm A W M Tiddens
Journal:  Eur Radiol       Date:  2017-05-18       Impact factor: 5.315

5.  Morphological features of bronchiectasis in patients with non-tuberculous mycobacteriosis and interstitial pneumonia.

Authors:  Chiori Tabe; Masaki Dobashi; Yoshiko Ishioka; Masamichi Itoga; Hisashi Tanaka; Kageaki Taima; Sadatomo Tasaka
Journal:  BMC Res Notes       Date:  2022-07-26

6.  Hepatopulmonary syndrome has low prevalence of pulmonary vascular abnormalities on chest computed tomography.

Authors:  Luciano Folador; Felipe S Torres; Juliana F Zampieri; Betina C Machado; Marli M Knorst; Marcelo B Gazzana
Journal:  PLoS One       Date:  2019-10-18       Impact factor: 3.240

7.  Chest computed tomography outcomes in a randomized clinical trial in cystic fibrosis: Lessons learned from the first ataluren phase 3 study.

Authors:  Harm A W M Tiddens; Eleni-Rosalina Andrinopoulou; Joe McIntosh; J Stuart Elborn; Eitan Kerem; Nynke Bouma; Jochem Bosch; Mariette Kemner-van de Corput
Journal:  PLoS One       Date:  2020-11-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.